Physician profile
Sundaram Ravikumar
NPI 1750441069
$1,788,934.71
in general payments reported to CMS, 2019-2025
18 companies · $220K in 2025
The $220K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303K · 2020: $265K · 2021: $265K · 2022: $265K · 2023: $237K · 2024: $235K · 2025: $220K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $677K · Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $676,533.30 |
| Long Term Medical Supply Or Device Loan | $14,400.00 |
| Food and Beverage | $364.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex Medical Incorporated | $1,753,426.46 | 2019-2025 | Percutaneous: Percuvance System, Percuvance, Deknatel |
| Angiodynamics, INC. | $33,600.00 | 2019-2025 | Venacure 1470 Pro |
| Abbott Laboratories | $363.43 | 2020-2023 | Jeti Peripheral Catheter, Perclose Proglide |
| Silk Road Medical, INC. | $303.95 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $249.85 | 2020-2021 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $224.32 | 2019 | |
| Endologix LLC | $175.84 | 2024-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Smith+Nephew, INC. | $140.71 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $124.86 | 2021 | |
| Lilly USA, LLC | $67.22 | 2019-2021 | |
| Cardiva Medical, INC. | $57.49 | 2021-2022 | |
| Tactile Systems Technology INC | $45.13 | 2019-2020 | |
| Resmed Corp | $35.15 | 2022 | |
| Bard Peripheral Vascular, INC. | $30.44 | 2021 | |
| Heartflow, INC. | $29.64 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $26.97 | 2022 | |
| Boston Scientific Corporation | $18.25 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sundaram Ravikumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.